Global Human Rabies Immune Globulin (HRIG) Market Insights, Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Human Rabies Immune Globulin (HRIG) Product Introduction 1.2 Market by Type 1.2.1 Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 200IU 1.2.3 500IU 1.3 Market by Application 1.3.1 Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Category II Exposure 1.3.3 Category III Exposure 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Human Rabies Immune Globulin (HRIG) Sales Estimates and Forecasts 2017-2028 2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Estimates and Forecasts 2017-2028 2.3 Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human Rabies Immune Globulin (HRIG) Sales by Region 2.4.1 Global Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2022) 2.4.2 Global Sales Human Rabies Immune Globulin (HRIG) by Region (2023-2028) 2.5 Global Human Rabies Immune Globulin (HRIG) Revenue by Region 2.5.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2022) 2.5.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers 3.1.1 Global Top Human Rabies Immune Globulin (HRIG) Manufacturers by Sales (2017-2022) 3.1.2 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Immune Globulin (HRIG) in 2021 3.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers 3.2.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (2017-2022) 3.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Immune Globulin (HRIG) Revenue in 2021 3.3 Global Human Rabies Immune Globulin (HRIG) Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human Rabies Immune Globulin (HRIG) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type 4.1.1 Global Human Rabies Immune Globulin (HRIG) Historical Sales by Type (2017-2022) 4.1.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Sales by Type (2023-2028) 4.1.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2017-2028) 4.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type 4.2.1 Global Human Rabies Immune Globulin (HRIG) Historical Revenue by Type (2017-2022) 4.2.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2017-2028) 4.3 Global Human Rabies Immune Globulin (HRIG) Price by Type 4.3.1 Global Human Rabies Immune Globulin (HRIG) Price by Type (2017-2022) 4.3.2 Global Human Rabies Immune Globulin (HRIG) Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Human Rabies Immune Globulin (HRIG) Sales by Application 5.1.1 Global Human Rabies Immune Globulin (HRIG) Historical Sales by Application (2017-2022) 5.1.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Sales by Application (2023-2028) 5.1.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2017-2028) 5.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application 5.2.1 Global Human Rabies Immune Globulin (HRIG) Historical Revenue by Application (2017-2022) 5.2.2 Global Human Rabies Immune Globulin (HRIG) Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2017-2028) 5.3 Global Human Rabies Immune Globulin (HRIG) Price by Application 5.3.1 Global Human Rabies Immune Globulin (HRIG) Price by Application (2017-2022) 5.3.2 Global Human Rabies Immune Globulin (HRIG) Price Forecast by Application (2023-2028)6 North America 6.1 North America Human Rabies Immune Globulin (HRIG) Market Size by Type 6.1.1 North America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 6.1.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 6.2 North America Human Rabies Immune Globulin (HRIG) Market Size by Application 6.2.1 North America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 6.2.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 6.3 North America Human Rabies Immune Globulin (HRIG) Market Size by Country 6.3.1 North America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 6.3.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Human Rabies Immune Globulin (HRIG) Market Size by Type 7.1.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 7.1.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 7.2 Europe Human Rabies Immune Globulin (HRIG) Market Size by Application 7.2.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 7.2.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 7.3 Europe Human Rabies Immune Globulin (HRIG) Market Size by Country 7.3.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 7.3.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Type 8.1.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 8.1.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 8.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Application 8.2.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 8.2.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 8.3 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size by Region 8.3.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2017-2028) 8.3.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Type 9.1.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 9.1.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 9.2 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Application 9.2.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 9.2.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 9.3 Latin America Human Rabies Immune Globulin (HRIG) Market Size by Country 9.3.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 9.3.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Type 10.1.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Type (2017-2028) 10.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Application 10.2.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Application (2017-2028) 10.3 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size by Country 10.3.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 CSL Behring 11.1.1 CSL Behring Corporation Information 11.1.2 CSL Behring Overview 11.1.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 CSL Behring Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 CSL Behring Recent Developments 11.2 Grifols 11.2.1 Grifols Corporation Information 11.2.2 Grifols Overview 11.2.3 Grifols Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Grifols Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Grifols Recent Developments 11.3 Sanofi 11.3.1 Sanofi Corporation Information 11.3.2 Sanofi Overview 11.3.3 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Sanofi Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Sanofi Recent Developments 11.4 Sichuan Yuanda Shuyang 11.4.1 Sichuan Yuanda Shuyang Corporation Information 11.4.2 Sichuan Yuanda Shuyang Overview 11.4.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Sichuan Yuanda Shuyang Recent Developments 11.5 CNBG 11.5.1 CNBG Corporation Information 11.5.2 CNBG Overview 11.5.3 CNBG Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 CNBG Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 CNBG Recent Developments 11.6 Kamada 11.6.1 Kamada Corporation Information 11.6.2 Kamada Overview 11.6.3 Kamada Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Kamada Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Kamada Recent Developments 11.7 CBPO 11.7.1 CBPO Corporation Information 11.7.2 CBPO Overview 11.7.3 CBPO Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 CBPO Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 CBPO Recent Developments 11.8 Shuanglin Bio 11.8.1 Shuanglin Bio Corporation Information 11.8.2 Shuanglin Bio Overview 11.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Shuanglin Bio Recent Developments 11.9 Weiguang Bio 11.9.1 Weiguang Bio Corporation Information 11.9.2 Weiguang Bio Overview 11.9.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Weiguang Bio Recent Developments 11.10 Shanghai RAAS 11.10.1 Shanghai RAAS Corporation Information 11.10.2 Shanghai RAAS Overview 11.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Shanghai RAAS Recent Developments 11.11 Bharat Serum 11.11.1 Bharat Serum Corporation Information 11.11.2 Bharat Serum Overview 11.11.3 Bharat Serum Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Bharat Serum Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Bharat Serum Recent Developments 11.12 VINS 11.12.1 VINS Corporation Information 11.12.2 VINS Overview 11.12.3 VINS Human Rabies Immune Globulin (HRIG) Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 VINS Human Rabies Immune Globulin (HRIG) Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 VINS Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Human Rabies Immune Globulin (HRIG) Industry Chain Analysis 12.2 Human Rabies Immune Globulin (HRIG) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human Rabies Immune Globulin (HRIG) Production Mode & Process 12.4 Human Rabies Immune Globulin (HRIG) Sales and Marketing 12.4.1 Human Rabies Immune Globulin (HRIG) Sales Channels 12.4.2 Human Rabies Immune Globulin (HRIG) Distributors 12.5 Human Rabies Immune Globulin (HRIG) Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human Rabies Immune Globulin (HRIG) Industry Trends 13.2 Human Rabies Immune Globulin (HRIG) Market Drivers 13.3 Human Rabies Immune Globulin (HRIG) Market Challenges 13.4 Human Rabies Immune Globulin (HRIG) Market Restraints14 Key Findings in The Global Human Rabies Immune Globulin (HRIG) Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer